Cargando…
17β-Hydroxysteroid Dehydrogenase Type 2 Expression Is Induced by Androgen Signaling in Endometrial Cancer
Endometrial cancer is one of the most common female pelvic cancers and has been considered an androgen-related malignancy. Several studies have demonstrated the anti-cell proliferative effect of androgen on endometrial cancer cells; however, the mechanisms of the anti-cancer effect of androgen remai...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979403/ https://www.ncbi.nlm.nih.gov/pubmed/29642629 http://dx.doi.org/10.3390/ijms19041139 |
_version_ | 1783327687989788672 |
---|---|
author | Hashimoto, Chiaki Miki, Yasuhiro Tanaka, Sota Takagi, Kiyoshi Fue, Misaki Doe, Zhulanqiqige Li, Bin Yaegashi, Nobuo Suzuki, Takashi Ito, Kiyoshi |
author_facet | Hashimoto, Chiaki Miki, Yasuhiro Tanaka, Sota Takagi, Kiyoshi Fue, Misaki Doe, Zhulanqiqige Li, Bin Yaegashi, Nobuo Suzuki, Takashi Ito, Kiyoshi |
author_sort | Hashimoto, Chiaki |
collection | PubMed |
description | Endometrial cancer is one of the most common female pelvic cancers and has been considered an androgen-related malignancy. Several studies have demonstrated the anti-cell proliferative effect of androgen on endometrial cancer cells; however, the mechanisms of the anti-cancer effect of androgen remain largely unclear. 17β-hydroxysteroid dehydrogenase type 2 (17β-HSD2), which catalyzes the conversion of E2 to E1, is known to be upregulated by androgen treatment in breast cancer cells. In this study, we therefore focused on the role of androgen on estrogen dependence in endometrial cancer. Dihydrotestosterone (DHT) was found to induce 17β-HSD2 mRNA and protein expression in HEC-1B endometrial cancer cells. DHT could also inhibit cell proliferation of HEC-1B when induced by estradiol treatment. In 19 endometrioid endometrial adenocarcinoma (EEA) tissues, intratumoral DHT concentration was measured by liquid chromatography/electrospray tandem mass spectrometry and was found to be significantly correlated with 17β-HSD2 immunohistochemical status. We further examined the correlations between 17β-HSD2 immunoreactivity and clinicopathological parameters in 53 EEA tissues. 17β-HSD2 status was inversely associated with the histological grade, clinical stage, and cell proliferation marker Ki-67, and positively correlated with progesterone receptor expression. 17β-HSD2 status tended to be positively associated with androgen receptor status. In 53 EEA cases, the 17β-HSD2-positive group tended to have better prognosis than that for the negative group with respect to progression-free survival and endometrial cancer-specific survival. These findings suggest that androgen suppresses the estrogen dependence of endometrial cancer through the induction of 17β-HSD2 in endometrial cancer. |
format | Online Article Text |
id | pubmed-5979403 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-59794032018-06-10 17β-Hydroxysteroid Dehydrogenase Type 2 Expression Is Induced by Androgen Signaling in Endometrial Cancer Hashimoto, Chiaki Miki, Yasuhiro Tanaka, Sota Takagi, Kiyoshi Fue, Misaki Doe, Zhulanqiqige Li, Bin Yaegashi, Nobuo Suzuki, Takashi Ito, Kiyoshi Int J Mol Sci Article Endometrial cancer is one of the most common female pelvic cancers and has been considered an androgen-related malignancy. Several studies have demonstrated the anti-cell proliferative effect of androgen on endometrial cancer cells; however, the mechanisms of the anti-cancer effect of androgen remain largely unclear. 17β-hydroxysteroid dehydrogenase type 2 (17β-HSD2), which catalyzes the conversion of E2 to E1, is known to be upregulated by androgen treatment in breast cancer cells. In this study, we therefore focused on the role of androgen on estrogen dependence in endometrial cancer. Dihydrotestosterone (DHT) was found to induce 17β-HSD2 mRNA and protein expression in HEC-1B endometrial cancer cells. DHT could also inhibit cell proliferation of HEC-1B when induced by estradiol treatment. In 19 endometrioid endometrial adenocarcinoma (EEA) tissues, intratumoral DHT concentration was measured by liquid chromatography/electrospray tandem mass spectrometry and was found to be significantly correlated with 17β-HSD2 immunohistochemical status. We further examined the correlations between 17β-HSD2 immunoreactivity and clinicopathological parameters in 53 EEA tissues. 17β-HSD2 status was inversely associated with the histological grade, clinical stage, and cell proliferation marker Ki-67, and positively correlated with progesterone receptor expression. 17β-HSD2 status tended to be positively associated with androgen receptor status. In 53 EEA cases, the 17β-HSD2-positive group tended to have better prognosis than that for the negative group with respect to progression-free survival and endometrial cancer-specific survival. These findings suggest that androgen suppresses the estrogen dependence of endometrial cancer through the induction of 17β-HSD2 in endometrial cancer. MDPI 2018-04-10 /pmc/articles/PMC5979403/ /pubmed/29642629 http://dx.doi.org/10.3390/ijms19041139 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hashimoto, Chiaki Miki, Yasuhiro Tanaka, Sota Takagi, Kiyoshi Fue, Misaki Doe, Zhulanqiqige Li, Bin Yaegashi, Nobuo Suzuki, Takashi Ito, Kiyoshi 17β-Hydroxysteroid Dehydrogenase Type 2 Expression Is Induced by Androgen Signaling in Endometrial Cancer |
title | 17β-Hydroxysteroid Dehydrogenase Type 2 Expression Is Induced by Androgen Signaling in Endometrial Cancer |
title_full | 17β-Hydroxysteroid Dehydrogenase Type 2 Expression Is Induced by Androgen Signaling in Endometrial Cancer |
title_fullStr | 17β-Hydroxysteroid Dehydrogenase Type 2 Expression Is Induced by Androgen Signaling in Endometrial Cancer |
title_full_unstemmed | 17β-Hydroxysteroid Dehydrogenase Type 2 Expression Is Induced by Androgen Signaling in Endometrial Cancer |
title_short | 17β-Hydroxysteroid Dehydrogenase Type 2 Expression Is Induced by Androgen Signaling in Endometrial Cancer |
title_sort | 17β-hydroxysteroid dehydrogenase type 2 expression is induced by androgen signaling in endometrial cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979403/ https://www.ncbi.nlm.nih.gov/pubmed/29642629 http://dx.doi.org/10.3390/ijms19041139 |
work_keys_str_mv | AT hashimotochiaki 17bhydroxysteroiddehydrogenasetype2expressionisinducedbyandrogensignalinginendometrialcancer AT mikiyasuhiro 17bhydroxysteroiddehydrogenasetype2expressionisinducedbyandrogensignalinginendometrialcancer AT tanakasota 17bhydroxysteroiddehydrogenasetype2expressionisinducedbyandrogensignalinginendometrialcancer AT takagikiyoshi 17bhydroxysteroiddehydrogenasetype2expressionisinducedbyandrogensignalinginendometrialcancer AT fuemisaki 17bhydroxysteroiddehydrogenasetype2expressionisinducedbyandrogensignalinginendometrialcancer AT doezhulanqiqige 17bhydroxysteroiddehydrogenasetype2expressionisinducedbyandrogensignalinginendometrialcancer AT libin 17bhydroxysteroiddehydrogenasetype2expressionisinducedbyandrogensignalinginendometrialcancer AT yaegashinobuo 17bhydroxysteroiddehydrogenasetype2expressionisinducedbyandrogensignalinginendometrialcancer AT suzukitakashi 17bhydroxysteroiddehydrogenasetype2expressionisinducedbyandrogensignalinginendometrialcancer AT itokiyoshi 17bhydroxysteroiddehydrogenasetype2expressionisinducedbyandrogensignalinginendometrialcancer |